Jean Martin Beaulieu - Publications

Université Laval, Ville de Québec, Québec, Canada 
Dopamine, signaling, pharmacology

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Khlghatyan J, Evstratova A, Bozoyan L, Chamberland S, Chatterjee D, Marakhovskaia A, Soares Silva T, Toth K, Mongrain V, Beaulieu JM. Fxr1 regulates sleep and synaptic homeostasis. The Embo Journal. e103864. PMID 32893934 DOI: 10.15252/embj.2019103864  0.36
2020 Khlghatyan J, Beaulieu JM. CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor-Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional Regulation. The Crispr Journal. 3: 198-210. PMID 32584144 DOI: 10.1089/crispr.2019.0075  0.36
2020 Magno LAV, Tenza-Ferrer H, Collodetti M, Nicolau ES, Khlghatyan J, Del'Guidice T, Romano-Silva MA, Beaulieu JM. Contribution of neuronal calcium sensor 1 (Ncs-1) to anxiolytic-like and social behavior mediated by valproate and Gsk3 inhibition. Scientific Reports. 10: 4566. PMID 32165725 DOI: 10.1038/s41598-020-61248-z  0.36
2019 Ouimet B, Pépin É, Bergeron Y, Chagniel L, Beaulieu JM, Massicotte G, Cyr M. Motor learning deficits and striatal GSK-3 hyperactivity in Akt3 knockout mice. Behavioral Neuroscience. 133: 135-143. PMID 30688489 DOI: 10.1037/bne0000292  0.44
2018 Khlghatyan J, Quintana C, Parent M, Beaulieu JM. High Sensitivity Mapping of Cortical Dopamine D2 Receptor Expressing Neurons. Cerebral Cortex (New York, N.Y. : 1991). PMID 30295716 DOI: 10.1093/cercor/bhy261  0.36
2018 Khlghatyan J, Beaulieu JM. Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses? Frontiers in Synaptic Neuroscience. 10: 22. PMID 30087606 DOI: 10.3389/fnsyn.2018.00022  0.36
2018 Khlghatyan J, Evstratova A, Chamberland S, Marakhovskaia A, Bahremand A, Toth K, Beaulieu JM. Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission. Frontiers in Molecular Neuroscience. 11: 119. PMID 29706865 DOI: 10.3389/fnmol.2018.00119  0.36
2015 Etiévant A, Manta S, Latapy C, Magno LA, Fecteau S, Beaulieu JM. Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation. Scientific Reports. 5: 16873. PMID 26585834 DOI: 10.1038/srep16873  0.96
2015 Lemay F, Doré FY, Beaulieu JM. Increased ethanol consumption despite taste aversion in mice with a human tryptophan hydroxylase 2 loss of function mutation. Neuroscience Letters. 609: 194-197. PMID 26497913 DOI: 10.1016/j.neulet.2015.10.045  0.96
2015 Del' Guidice T, Beaulieu JM. Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers. Journal of Receptor and Signal Transduction Research. 35: 224-32. PMID 26459714 DOI: 10.3109/10799893.2015.1072976  0.96
2015 Del'Guidice T, Latapy C, Rampino A, Khlghatyan J, Lemasson M, Gelao B, Quarto T, Rizzo G, Barbeau A, Lamarre C, Bertolino A, Blasi G, Beaulieu JM. FXR1P is a GSK3β substrate regulating mood and emotion processing. Proceedings of the National Academy of Sciences of the United States of America. 112: E4610-9. PMID 26240334 DOI: 10.1073/pnas.1506491112  0.96
2015 Thériault O, Poulin H, Beaulieu JM, Chahine M. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs. European Journal of Pharmacology. 764: 395-403. PMID 26187311 DOI: 10.1016/j.ejphar.2015.06.053  0.96
2015 Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. British Journal of Pharmacology. 172: 1-23. PMID 25671228 DOI: 10.1111/bph.12906  0.96
2015 Lavoie J, Hébert M, Beaulieu JM. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium? Biological Psychiatry. 77: e15-7. PMID 25193244 DOI: 10.1016/j.biopsych.2014.07.024  0.96
2015 Khlghatyan J, Fakhfouri G, Beaulieu JM. GSK3 networks in schizophrenia Rsc Drug Discovery Series. 2015: 173-201.  0.96
2014 Poulin H, Bruhova I, Timour Q, Theriault O, Beaulieu JM, Frassati D, Chahine M. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics. Molecular Pharmacology. 86: 378-89. PMID 25028482 DOI: 10.1124/mol.114.093104  0.96
2014 Petryszyn S, Beaulieu JM, Parent A, Parent M. Distribution and morphological characteristics of striatal interneurons expressing calretinin in mice: a comparison with human and nonhuman primates. Journal of Chemical Neuroanatomy. 59: 51-61. PMID 24960462 DOI: 10.1016/j.jchemneu.2014.06.002  0.96
2014 Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein. The Journal of Biological Chemistry. 289: 11715-24. PMID 24619418 DOI: 10.1074/jbc.M113.544312  0.96
2014 Del'Guidice T, Lemay F, Lemasson M, Levasseur-Moreau J, Manta S, Etievant A, Escoffier G, Doré FY, Roman FS, Beaulieu JM. Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1125-34. PMID 24196946 DOI: 10.1038/npp.2013.313  0.96
2014 Lavoie J, Hébert M, Beaulieu JM. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder. Biological Psychiatry. 76: 93-100. PMID 24138923 DOI: 10.1016/j.biopsych.2013.08.035  0.96
2014 Del'Guidice T, Lemasson M, Etiévant A, Manta S, Magno LA, Escoffier G, Roman FS, Beaulieu JM. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice. Psychopharmacology. 231: 109-22. PMID 23912772 DOI: 10.1007/s00213-013-3212-8  0.96
2014 Chakraborty A, Latapy C, Xu J, Snyder SH, Beaulieu JM. Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways. Molecular Psychiatry. 19: 284-93. PMID 23439485 DOI: 10.1038/mp.2013.21  0.96
2014 Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biological Psychiatry. 75: 479-86. PMID 23305992 DOI: 10.1016/j.biopsych.2012.11.024  0.96
2013 Medvedev IO, Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A. D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18125-33. PMID 24227722 DOI: 10.1523/JNEUROSCI.2382-13.2013  0.96
2013 Barbeau A, Swift JL, Godin AG, De Koninck Y, Wiseman PW, Beaulieu JM. Spatial intensity distribution analysis (SpIDA): a new tool for receptor tyrosine kinase activation and transactivation quantification. Methods in Cell Biology. 117: 1-19. PMID 24143969 DOI: 10.1016/B978-0-12-408143-7.00001-3  0.96
2013 Lavoie J, Hébert M, Beaulieu JM. Glycogen synthase kinase-3β haploinsufficiency lengthens the circadian locomotor activity period in mice. Behavioural Brain Research. 253: 262-5. PMID 23919927 DOI: 10.1016/j.bbr.2013.08.001  0.96
2013 Latapy C, Beaulieu JM. β-Arrestins in the central nervous system. Progress in Molecular Biology and Translational Science. 118: 267-95. PMID 23764058 DOI: 10.1016/B978-0-12-394440-5.00011-5  0.96
2013 Barbeau A, Godin AG, Swift JL, De Koninck Y, Wiseman PW, Beaulieu JM. Quantification of receptor tyrosine kinase activation and transactivation by G-protein-coupled receptors using spatial intensity distribution analysis (SpIDA). Methods in Enzymology. 522: 109-31. PMID 23374183 DOI: 10.1016/B978-0-12-407865-9.00007-8  0.96
2013 Siesser WB, Sachs BD, Ramsey AJ, Sotnikova TD, Beaulieu JM, Zhang X, Caron MG, Gainetdinov RR. Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice. Acs Chemical Neuroscience. 4: 84-8. PMID 23336047 DOI: 10.1021/cn300127h  0.96
2013 Ferrini F, Trang T, Mattioli TA, Laffray S, Del'Guidice T, Lorenzo LE, Castonguay A, Doyon N, Zhang W, Godin AG, Mohr D, Beggs S, Vandal K, Beaulieu JM, Cahill CM, et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nature Neuroscience. 16: 183-92. PMID 23292683 DOI: 10.1038/nn.3295  0.96
2012 Zhou W, Chen L, Paul J, Yang S, Li F, Sampson K, Woodgett JR, Beaulieu JM, Gamble KL, Li X. The effects of glycogen synthase kinase-3beta in serotonin neurons. Plos One. 7: e43262. PMID 22912839 DOI: 10.1371/journal.pone.0043262  0.96
2012 Lalancette-Hébert M, Swarup V, Beaulieu JM, Bohacek I, Abdelhamid E, Weng YC, Sato S, Kriz J. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10383-95. PMID 22836271 DOI: 10.1523/JNEUROSCI.1498-12.2012  0.96
2012 Latapy C, Rioux V, Guitton MJ, Beaulieu JM. Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 2460-74. PMID 22826345 DOI: 10.1098/rstb.2012.0094  0.96
2012 Kaidanovich-Beilin O, Beaulieu JM, Jope RS, Woodgett JR. Neurological functions of the masterswitch protein kinase - gsk-3. Frontiers in Molecular Neuroscience. 5: 48. PMID 22509152 DOI: 10.3389/fnmol.2012.00048  0.96
2012 Freland L, Beaulieu JM. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Frontiers in Molecular Neuroscience. 5: 14. PMID 22363263 DOI: 10.3389/fnmol.2012.00014  0.96
2012 Beaulieu JM. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. Journal of Psychiatry & Neuroscience : Jpn. 37: 7-16. PMID 21711983 DOI: 10.1503/jpn.110011  0.96
2011 Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience. 4: 38. PMID 22065948 DOI: 10.3389/fnmol.2011.00038  0.8
2011 Del'guidice T, Lemasson M, Beaulieu JM. Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia. Frontiers in Neuroanatomy. 5: 58. PMID 21922001 DOI: 10.3389/fnana.2011.00058  0.96
2011 Swift JL, Godin AG, Doré K, Freland L, Bouchard N, Nimmo C, Sergeev M, De Koninck Y, Wiseman PW, Beaulieu JM. Quantification of receptor tyrosine kinase transactivation through direct dimerization and surface density measurements in single cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 7016-21. PMID 21482778 DOI: 10.1073/pnas.1018280108  0.96
2011 Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews. 63: 182-217. PMID 21303898 DOI: 10.1124/pr.110.002642  0.96
2010 Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. The dopamine metabolite 3-methoxytyramine is a neuromodulator. Plos One. 5: e13452. PMID 20976142 DOI: 10.1371/journal.pone.0013452  0.96
2010 Del'Guidice T, Beaulieu JM. [Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses]. MéDecine Sciences : M/S. 26: 647-51. PMID 20619169 DOI: 10.1051/medsci/2010266-7647  0.96
2010 Zhang ZW, Burke MW, Calakos N, Beaulieu JM, Vaucher E. Confocal Analysis of Cholinergic and Dopaminergic Inputs onto Pyramidal Cells in the Prefrontal Cortex of Rodents. Frontiers in Neuroanatomy. 4: 21. PMID 20589096 DOI: 10.3389/fnana.2010.00021  0.96
2009 Beaulieu JM, Gainetdinov RR, Caron MG. Akt/GSK3 signaling in the action of psychotropic drugs. Annual Review of Pharmacology and Toxicology. 49: 327-47. PMID 18928402 DOI: 10.1146/annurev.pharmtox.011008.145634  0.96
2008 Beaulieu JM, Caron MG. Looking at lithium: molecular moods and complex behaviour. Molecular Interventions. 8: 230-41. PMID 19015387 DOI: 10.1124/mi.8.5.8  0.96
2008 Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proceedings of the National Academy of Sciences of the United States of America. 105: 13656-61. PMID 18768802 DOI: 10.1073/pnas.0803522105  0.96
2008 Murphy KL, Zhang X, Gainetdinov RR, Beaulieu JM, Caron MG. A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression. The Journal of Biological Chemistry. 283: 13216-24. PMID 18339632 DOI: 10.1074/jbc.M706749200  0.96
2008 Del'guidice T, Beaulieu JM. Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivo. Molecular Pharmacology. 73: 1339-42. PMID 18314495 DOI: 10.1124/mol.108.046540  0.96
2008 Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, Gainetdinov RR, Caron MG. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America. 105: 1333-8. PMID 18212115 DOI: 10.1073/pnas.0711496105  0.96
2008 Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, Wetsel WC, Lefkowitz RJ, Gainetdinov RR, Caron MG. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell. 132: 125-36. PMID 18191226 DOI: 10.1016/j.cell.2007.11.041  0.96
2008 Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Wetsel WC, Gainetdinov RR, Caron MG. Reply to Belmaker et al.: GSK3β haploinsufficiency results in lithium-like effects in the forced-swim test Proceedings of the National Academy of Sciences of the United States of America. 105: E24. DOI: 10.1073/pnas.0803026105  0.96
2007 Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacological Sciences. 28: 166-72. PMID 17349698 DOI: 10.1016/  0.96
2007 Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 881-5. PMID 17251429 DOI: 10.1523/JNEUROSCI.5074-06.2007  0.96
2007 Beaulieu JM. Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 3-6. PMID 16784549 DOI: 10.1017/S1461145706006857  0.96
2007 Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biological Psychiatry. 61: 65-9. PMID 16712807 DOI: 10.1016/j.biopsych.2006.03.020  0.96
2006 Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. The Journal of Biological Chemistry. 281: 32072-80. PMID 16954211 DOI: 10.1074/jbc.M606062200  0.96
2006 Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. Cns & Neurological Disorders Drug Targets. 5: 45-56. PMID 16613553 DOI: 10.2174/187152706784111579  0.96
2006 Zhang X, Beaulieu JM, Gainetdinov RR, Caron MG. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cellular and Molecular Life Sciences : Cmls. 63: 6-11. PMID 16378243 DOI: 10.1007/s00018-005-5417-4  0.96
2005 Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, McGrath PJ, Rush J, Trivedi MH, Charney DS, Roy A, Wisniewski S, Lipsky R, Goldman D, Van Den Bogaert A, De Zutter S, ... ... Beaulieu JM, et al. Response to Zhang et al. (2005) loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16 [2] (multiple letters) Neuron. 48: 702-706. PMID 16337901 DOI: 10.1016/j.neuron.2005.11.018  0.96
2005 Beaulieu JM, Caron MG. Beta-arrestin goes nuclear. Cell. 123: 755-7. PMID 16325568 DOI: 10.1016/j.cell.2005.11.010  0.96
2005 Beaulieu JM. Morphine-induced mu-opioid receptor internalization: a paradox solved in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10061-3. PMID 16267212 DOI: 10.1523/JNEUROSCI.3914-05.2005  0.96
2005 Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 122: 261-73. PMID 16051150 DOI: 10.1016/j.cell.2005.05.012  0.96
2005 Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. Plos Biology. 3: e271. PMID 16050778 DOI: 10.1371/journal.pbio.0030271  0.96
2005 Kriz J, Beaulieu JM, Julien JP, Krnjević K. Up-regulation of peripherin is associated with alterations in synaptic plasticity in CA1 and CA3 regions of hippocampus. Neurobiology of Disease. 18: 409-20. PMID 15686970 DOI: 10.1016/j.nbd.2004.10.009  0.96
2005 Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KR, Caron MG. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 45: 11-6. PMID 15629698 DOI: 10.1016/j.neuron.2004.12.014  0.96
2004 Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proceedings of the National Academy of Sciences of the United States of America. 101: 15650-5. PMID 15505207 DOI: 10.1073/pnas.0308088101  0.96
2004 Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (New York, N.Y.). 305: 217. PMID 15247473 DOI: 10.1126/science.1097540  0.96
2004 Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America. 101: 5099-104. PMID 15044694 DOI: 10.1073/pnas.0307921101  0.96
2004 Zhang G, Spencer PH, Jin LQ, Cohlberg JA, Beaulieu JM, Julien JP, Selzer ME. The single neurofilament subunit of lamprey may need another element for filament assembly. The Journal of Comparative Neurology. 471: 188-200. PMID 14986312 DOI: 10.1002/cne.20026  0.96
2004 Yao WD, Gainetdinov RR, Arbuckle MI, Sotnikova TD, Cyr M, Beaulieu JM, Torres GE, Grant SG, Caron MG. Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron. 41: 625-38. PMID 14980210 DOI: 10.1016/S0896-6273(04)00048-0  0.96
2003 Cyr M, Beaulieu JM, Laakso A, Sotnikova TD, Yao WD, Bohn LM, Gainetdinov RR, Caron MG. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 100: 11035-40. PMID 12958210 DOI: 10.1073/pnas.1831768100  0.96
2003 Larivière RC, Beaulieu JM, Nguyen MD, Julien JP. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Neurobiology of Disease. 13: 158-66. PMID 12828939 DOI: 10.1016/S0969-9961(03)00036-6  0.96
2003 Beaulieu JM, Julien JP. Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins. Journal of Neurochemistry. 85: 248-56. PMID 12641746  0.96
2002 Carneiro AM, Ingram SL, Beaulieu JM, Sweeney A, Amara SG, Thomas SM, Caron MG, Torres GE. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7045-54. PMID 12177201  0.96
2002 Beaulieu JM, Kriz J, Julien JP. Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia. Brain Research. 946: 153-61. PMID 12137917 DOI: 10.1016/S0006-8993(02)02830-5  0.96
2001 Robertson J, Beaulieu JM, Doroudchi MM, Durham HD, Julien JP, Mushynski WE. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. The Journal of Cell Biology. 155: 217-26. PMID 11604419 DOI: 10.1083/jcb.200107058  0.96
2000 Julien JP, Beaulieu JM. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects? Journal of the Neurological Sciences. 180: 7-14. PMID 11090858 DOI: 10.1016/S0022-510X(00)00422-6  0.96
2000 Beaulieu JM, Jacomy H, Julien JP. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5321-8. PMID 10884316  0.96
1999 Beaulieu JM, Nguyen MD, Julien JP. Late onset of motor neurons in mice overexpressing wild-type peripherin. The Journal of Cell Biology. 147: 531-44. PMID 15132161 DOI: 10.1083/jcb.147.3.531  0.96
1999 Jacomy H, Zhu Q, Couillard-Després S, Beaulieu JM, Julien JP. Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. Journal of Neurochemistry. 73: 972-84. PMID 10461886 DOI: 10.1046/j.1471-4159.1999.0730972.x  0.96
1999 Beaulieu JM, Robertson J, Julien JP. Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 77: 41-5. PMID 10426285 DOI: 10.1139/bcb-77-1-41  0.96
Show low-probability matches.